Huashen Technology (000790.SZ) subsidiary plans to sell 5.4% stake in Shanghai Lingkai for 200 million yuan.

Zhongtong Financial APP News, Huashen Technology (000790.SZ) announced that its subsidiary Hainan Huashen Xingrui Pharmaceutical Technology Co., Ltd. ("Xingrui Pharmaceutical") plans to transfer its 5.4019% stake in Shanghai Lingkai Technology Co., Ltd. ("Shanghai Lingkai") to Lu Qian for RMB 200 million. After the completion of this transaction, Xingrui Pharmaceutical will no longer hold any shares in Shanghai Lingkai.